Rocket


News + Filings
Transactions





All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other



Tessier-Lavigne Marc Create: Alert

All | News | Filings
Date FiledTypeDescription
10/03/2023 144 Form 144 - Report of proposed sale of securities:
06/05/2023 4 Tessier-Lavigne Marc (Director) has filed a Form 4 on Denali Therapeutics Inc.
Txns: Granted 4,216 shares @ $0
Granted 12,649 options to buy @ $30.92, valued at $391.1k
01/05/2023 4 Tessier-Lavigne Marc (Director) has filed a Form 4 on REGENERON PHARMACEUTICALS, INC.
Txns: Granted 165 shares @ $0
Granted 1,929 options to buy @ $725.89, valued at $1.4M
01/05/2023 4 Tessier-Lavigne Marc (Director) has filed a Form 4 on REGENERON PHARMACEUTICALS, INC.
Txns: Granted 165 shares @ $0
Granted 1,929 options to buy @ $725.89, valued at $1.4M
11/28/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
11/03/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
10/03/2022 4 Tessier-Lavigne Marc (Director) has filed a Form 4 on REGENERON PHARMACEUTICALS, INC.
Txns: Sold 16 shares @ $686.89, valued at $11k
Sold 321 shares @ $687.9, valued at $220.8k
Sold 637 shares @ $688.71, valued at $438.7k
Sold 1,009 shares @ $689.56, valued at $695.8k
Sold 692 shares @ $690.65, valued at $477.9k
Sold 554 shares @ $691.59, valued at $383.1k
Sold 85 shares @ $696.13, valued at $59.2k
Sold 160 shares @ $697.29, valued at $111.6k
Sold 208 shares @ $698.44, valued at $145.3k
Sold 80 shares @ $699.82, valued at $56k
Sold 16 shares @ $702.36, valued at $11.2k
09/30/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
08/25/2022 4 Tessier-Lavigne Marc (Director) has filed a Form 4 on Denali Therapeutics Inc.
Txns: Sold 19,900 shares @ $31.61, valued at $629k
Sold 100 shares @ $32.43, valued at $3.2k
07/27/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
06/28/2022 4/A Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]
06/27/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
06/06/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
03/25/2022 4 Tessier-Lavigne Marc (Director) has filed a Form 4 on Denali Therapeutics Inc.
Txns: Sold 8,402 shares @ $33.4, valued at $280.6k
Sold 11,598 shares @ $34.14, valued at $396k
03/23/2022 4 Tessier-Lavigne Marc (Director) has filed a Form 4 on REGENERON PHARMACEUTICALS, INC.
Txns: Sold 7,439 shares @ $690, valued at $5.1M
Exercised 7,439 options to buy @ $380.95, valued at $2.8M
03/18/2022 4 Tessier-Lavigne Marc (Director) has filed a Form 4 on REGENERON PHARMACEUTICALS, INC.
Txns: Sold 4,361 shares @ $675, valued at $2.9M
Sold 7,830 shares @ $680, valued at $5.3M
Exercised 4,361 options to buy @ $374.12, valued at $1.6M
Exercised 7,830 options to buy @ $376.69, valued at $2.9M
02/17/2022 5 Tessier-Lavigne Marc (Director) has filed a Form 5 on Denali Therapeutics Inc.
01/05/2022 4 Tessier-Lavigne Marc (Director) has filed a Form 4 on REGENERON PHARMACEUTICALS, INC.
Txns: Granted 191 shares @ $0
Granted 2,707 options to buy @ $625.6, valued at $1.7M
12/30/2021 4 Tessier-Lavigne Marc (Director) has filed a Form 4 on Denali Therapeutics Inc.
Txns: Gifted 300,000 shares @ $0
Gifted 100,000 shares @ $0
Sold 3,732 shares @ $44.37, valued at $165.6k
Sold 10,700 shares @ $43.88, valued at $469.5k
Sold 3,343 shares @ $45.13, valued at $150.9k
Sold 3,377 shares @ $45.59, valued at $154k
Gifted 100,000 shares @ $0
Sold 3,602 shares @ $44.38, valued at $159.9k
Sold 10,700 shares @ $43.87, valued at $469.4k
Sold 5,625 shares @ $45.31, valued at $254.9k
Sold 900 shares @ $45.71, valued at $41.1k
12/10/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
09/15/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
06/08/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
06/04/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
05/24/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
05/05/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
04/05/2021 4 Tessier-Lavigne Marc (Director) has filed a Form 4 on Denali Therapeutics Inc.
Txns: Sold 14,223 shares @ $55.606, valued at $790.9k
Sold 29,593 shares @ $56.906, valued at $1.7M
Sold 6,184 shares @ $57.595, valued at $356.2k
03/03/2021 4 Tessier-Lavigne Marc (Director) has filed a Form 4 on Denali Therapeutics Inc.
Txns: Sold 18,770 shares @ $64.361, valued at $1.2M
Sold 37,445 shares @ $65.634, valued at $2.5M
Sold 18,316 shares @ $66.554, valued at $1.2M
Sold 14,945 shares @ $67.57, valued at $1M
Sold 6,011 shares @ $68.504, valued at $411.8k
Sold 3,482 shares @ $69.589, valued at $242.3k
Sold 1,031 shares @ $71.351, valued at $73.6k
01/05/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
06/18/2020 4 Tessier-Lavigne Marc (Director) has filed a Form 4 on Denali Therapeutics Inc.
Txns: Sold 400,000 shares @ $26.1, valued at $10.4M
06/05/2020 4 Tessier-Lavigne Marc (Director) has filed a Form 4 on Denali Therapeutics Inc.
Txns: Granted 15,183 options to buy @ $28.82, valued at $437.6k
Granted 3,253 restricted stock units @ $0
05/08/2020 4 Form 4 - Statement of changes in beneficial ownership of securities:
02/14/2020 4 Form 4 - Statement of changes in beneficial ownership of securities:
01/06/2020 4 Tessier-Lavigne Marc (Director) has filed a Form 4 on REGENERON PHARMACEUTICALS, INC.
Txns: Granted 320 shares @ $0
Granted 4,361 options to buy @ $374.12, valued at $1.6M
05/31/2019 4 Tessier-Lavigne Marc (Director) has filed a Form 4 on Denali Therapeutics Inc.
Txns: Granted 27,245 options to buy @ $19.5, valued at $531.3k
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy